Series B funding round for Memo Therapeutics raising $25M in February 2022
Series B funding round for Memo Therapeutics raising $25M in February 2022
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 6 funding rounds. Current round is highlighted.
Total Raised
$97.9M
Top Valuation
-
Memo Therapeutics raised $25M in a Series B round.
The round was announced on 02/01/22.
The round was led by Swisscanto Invest, Swiss Federal Office of Public Health.